Comparing two surgical methods for shoulder dislocation treatment
Latarjet vs Anatomic Glenoid Reconstruction for Treatment of Anterior Shoulder Instability With Glenoid Bone Loss: a Prospective Multi-centre Randomized Trial
This study is testing which of two shoulder surgeries, the Latarjet procedure or Anatomic Glenoid Reconstruction, works better for people with significant bone loss after multiple dislocations.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 68 (estimated) |
| Ages | 16 Years to 40 Years |
| Sex | All |
| Sponsor | Nova Scotia Health Authority Academic / other |
| Locations | 1 site (Halifax, Nova Scotia) |
| Trial ID | NCT05658289 on ClinicalTrials.gov |
What this trial studies
This clinical trial compares the effectiveness of the Latarjet procedure and Anatomic Glenoid Reconstruction (AGR) in treating anterior shoulder dislocations with significant bone loss. Both surgical techniques aim to reduce the risk of recurrent dislocations and improve patient outcomes, including pain relief and functional recovery. The study involves patients who have experienced one or more shoulder dislocations and have a pre-operative CT scan showing over 20% bone loss. Participants will be randomly assigned to receive either the Latarjet or AGR intervention.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have experienced anterior shoulder dislocations and have significant glenoid bone loss as indicated by imaging.
Not a fit: Patients with posterior or multidirectional shoulder instability, massive rotator cuff tears, or those unable to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide patients with a more effective surgical option for preventing recurrent shoulder dislocations.
How similar studies have performed: Previous studies have shown success with both the Latarjet and AGR approaches, but this trial aims to directly compare their outcomes in a controlled setting.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with one or more instances of anterior shoulder dislocation; pre-operative CT scan illustrating \>20% bone loss. Exclusion Criteria: * posterior shoulder instability; multidirectional shoulder instability; massive rotator cuff teats (MRI proven); history of substance abuse, patients unable to provide informed consent, patients refusing randomization.
Where this trial is running
Halifax, Nova Scotia
- Nova Scotia Health QEII Halifax Infirmary — Halifax, Nova Scotia, Canada (Recruiting)
Study contacts
- Principal investigator: Ivan Wong, MD — Nova Scotia Health Authority, Orthopaedic Surgeon
- Study coordinator: Ivan Wong, MD
- Email: research@drivanwong.com
- Phone: 9024737626
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.